# The Effect of Interscalene Peripheral Nerve Block With 0.25% Bupivacaine vs 0.125% Bupivacaine on Lung Function

> **NCT01429584** · NA · COMPLETED · sponsor: **University of Utah** · enrollment: 30 (actual)

## Conditions studied

- Diaphragm Paralysis

## Interventions

- **DRUG:** interscalene nerve block with 0.25% bupivacaine
- **DRUG:** interscalene block with 0.125% bupivacaine

## Key facts

- **NCT ID:** NCT01429584
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429584, "The Effect of Interscalene Peripheral Nerve Block With 0.25% Bupivacaine vs 0.125% Bupivacaine on Lung Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01429584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*